Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07520903) titled 'Titanium-Reinforced PTFE Membranes for Bone Augmentation' on April 2.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Universidade do Porto
Condition:
Alveolar Ridge Deficiency
Alveolar Bone Loss
Jaw Atrophy
Intervention:
Device: Titanium-reinforced dense PTFE membrane (TiR-dPTFE)
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: April 1, 2022
Target Sample Size: 14
Countries of Recruitment:
Portugal
To know more, visit https://clinicaltrials.gov...